Tag: MindMed - Page 10 - Psychedelic Alpha

Read more about the article MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

Post published:August 13, 2020
Post category:Press Release

Read more about the article MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Post published:August 6, 2020
Post category:Press Release

Read more about the article MindMed Completes Dosing 18-MC Phase 1 Study

MindMed Completes Dosing 18-MC Phase 1 Study

Post published:July 28, 2020
Post category:Press Release

Read more about the article MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry

MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry

Post published:June 27, 2020
Post category:Press Release

Read more about the article MindMed Developing IP For Personalized Psychedelic Assisted Therapies

MindMed Developing IP For Personalized Psychedelic Assisted Therapies

Post published:June 24, 2020
Post category:Press Release

Read more about the article JR Rahn, MindMed

JR Rahn, MindMed

Post published:June 19, 2020
Post category:Interview

Read more about the article MindMed To Evaluate Ayahuasca’s Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

MindMed To Evaluate Ayahuasca’s Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

Post published:June 18, 2020
Post category:Press Release

Read more about the article MindMed: Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

MindMed: Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

Post published:June 8, 2020
Post category:Press Release

Read more about the article MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

Post published:June 4, 2020
Post category:Press Release

Read more about the article MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD

MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD

Post published:June 2, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.